Physician profile
Emil Dib
NPI 1104818970
$3,791.67
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $724 · 2020: $67.44 · 2021: $3,000.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,592.57 | 2019-2021 | |
| Hologic Sales and Service, LLC | $59.81 | 2019 | |
| Abbvie INC. | $38.80 | 2019-2020 | |
| Exeltis, USA INC. | $22.44 | 2019 | |
| Astellas Pharma US INC | $17.75 | 2019 | |
| Minerva Surgical, INC | $12.34 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.27 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.17 | 2019 | |
| Pfizer INC. | $11.98 | 2019 | |
| Merck Sharp & Dohme LLC | $11.54 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emil Dib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.